Podcast: How Does Fatty Liver Affect Risk for Cardiovascular Disease?

Modification of risk factors for cardiovascular disease—particularly dyslipidemia—is required to reduce morbidity and mortality in patients with nonalcoholic fatty liver disease (NAFLD). In a Perspective article published in the July issue of Clinical Gastroenterology and Hepatology, Kathleen E. Corey and Naga Chalasani discuss the increased risk of cardiovascular disease among patients with NAFLD, and strategies

Read more

Is it Safe for Patients With Cardiovascular Disease to Discontinue Low-Dose Aspirin Therapy?

In patients with cardiovascular disease, discontinuing low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events almost 7-fold, according to the January issue of Clinical Gastroenterology and Hepatology. Many patients with cardiovascular disease receive low-dose aspirin, for its cardioprotective effects. However, aspirin can also cause

Read more

An Aspirin a Day Won’t Kill You, But it Might Cause GI Bleeding

Taking an aspirin a day reduces the risk for death, but increases odds of gastrointestinal (GI) bleeding, according to a large meta-analysis published in the September issue of Clinical Gastroenterology and Hepatology. Daily low doses of acetylsalicylic acid (ASA, also known as aspirin, 75 to 325 mg per day) are

Read more